MeMed vs Picodya
MeMed vs Picodya, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: MeMed is on 61/100 and Picodya on 50/100.
Where each one leads
MeMed
- our overall score: 61/100 against 50/100
- agent readiness: 35/100 against 21/100
- domain rating: 46/100 against 8/100
- headcount: 99 against 27
- funding raised: $196M against $10.0M
- LinkedIn following: 21,207 against 1,860
Picodya
- headcount growth: +5.0% against -8.4%
At a glance
| Measure | MeMed | Picodya |
|---|---|---|
| What it is | MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes. | Developing advanced diagnostic technology to expand global access to healthcare. |
| Category | Healthcare, Blood, Diagnostics, MedTech | Healthcare, Diagnostics, HealthTech, MedTech |
| Sells toBusiness model | B2B, B2G | B2B |
| Offering | Software, Hardware | Hardware, Software |
| Founded | 2009 | 2018 |
| Headquarters | Tirat Carmel, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | MeMed | Picodya |
|---|---|---|
| Employees | 99 | 27 |
| Headcount growthLast 12 months | -8.4% | +5.0% |
| Total funding | $196M | $10.0M |
| Latest round | Series E | Not published |
| LinkedIn followers | 21,207 | 1,860 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | MeMed | Picodya |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 50/100 |
| Traction | 60/100 | 49/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 29/100 | 34/100 |
| Quality | 65/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 8/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | MeMed | Picodya |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Google Analytics 4 |
MeMed vs Picodya: common questions
Which is better, MeMed or Picodya?
On our 0-100 score MeMed rates higher (61/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do MeMed and Picodya compare on the numbers?
MeMed leads on our overall score (61/100 against 50/100), agent readiness (35/100 against 21/100), domain rating (46/100 against 8/100), headcount (99 against 27), funding raised ($196M against $10.0M), LinkedIn following (21,207 against 1,860). Picodya leads on headcount growth (+5.0% against -8.4%).
Read the full MeMed review and pricing or the Picodya review and pricing. You can also browse other MeMed alternatives we track.